Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
74.74 CHF | -0.64% | -1.24% | +13.86% |
Mar. 26 | Alcon Announces Management Changes | CI |
Mar. 26 | Alcon’s Medical Chief to Retire; Successor Named | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 41.11 and 31.71 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.98 times its current sales, is high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.86% | 40.93B | B | ||
+15.47% | 102B | B | ||
+7.24% | 20.17B | B- | ||
-20.68% | 2.22B | D+ | ||
-3.48% | 1.61B | C+ | ||
+14.50% | 1.11B | - | ||
-32.59% | 781M | B- | ||
-33.95% | 771M | - | ||
-1.44% | 723M | - | ||
+44.24% | 585M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Alcon Inc. - Swiss Exchange
- Ratings Alcon Inc.